Spyre Therapeutics (SYRE) Earnings Date & Reports

Industry: @Pharmaceuticals Major

A.I. Advisor

published Earnings

SYRE is expected to report earnings to rise 12.13% to -96 cents per share on November 07

Spyre Therapeutics SYRE Stock Earnings Reports

Q3'24

Est.

$-0.96

Q2'24

Beat

by $0.09

Q1'24

Missed

by $0.15

Q3'23

Missed

by $8.49

Q2'23

Missed

by $52.77

The last earnings report on August 08 showed earnings per share of -86 cents, beating the estimate of -94 cents. With 652.18K shares outstanding, the current market capitalization sits at 1.45B.

View a ticker or compare two or three

Compare

SYRE

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For SYRE
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for SYRE (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a biopharmaceutical company

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

221 Crescent Street

Phone

+1 617 651-5940

Employees

Web

https://www.spyre.com